Redwoods Acquisition Corp.
RWODR
NASDAQ Global Market0.21
USD
+0.21
- -
CIK
0001907223
ISIN
US7580831250
CUSIP
758083125
Return %
Stock
S&P500
1Y
- -
26.53
3Y
31.25
76.60
5Y
61.54
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jiande Chen
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1115 Broadway New York City NY United States of America 10010
- CIK
- 0001907223
- Website
- redwoodscorporation.com
- Similar Companies
- Business
- Redwoods Acquisition Corp. (NASDAQ:RWODR) is a blank check company, or special purpose acquisition company (SPAC), with no significant current operations that focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses; it historically targeted opportunities in carbon neutral and energy storage industries prior to its recent transaction. Incorporated in 2021 and headquartered in New York, New York, the company raises capital through public offerings including common stock, warrants, and rights trading separately under symbols RWOD, RWODW, and RWODR, to pursue strategic transactions across diverse sectors with an emphasis on rigorous due diligence, transparent governance, and long-term value creation for investors. In June 2024, Redwoods completed a reverse merger business combination with ANEW Medical, Inc., an early-stage biotechnology company developing disruptive gene therapies for neurodegenerative diseases including those targeting central nervous system disorders, resulting in ANEW becoming the surviving public entity under the name Anew Medical, Inc., listed on NASDAQ, with the deal providing approximately $54 million in proceeds assuming no redemptions and including earn-out provisions tied to post-closing stock performance; this transaction followed a definitive agreement announced in May 2023 and recent forward purchase agreements with Meteora Capital entities in June 2024, marking the culmination of Redwoods' SPAC mission.